About Us | US BioTech Co

Our Company

Our cutting-edge bio-technology company harnesses the power of advanced technology to address the urgent need for disease identification in animals, particularly in third-world countries. We believe that by effectively tackling the prevalence of diseases in animal populations, we can contribute to the crucial task of safeguarding human health and combating the declining populations in these regions. Leveraging our innovative bio-technology platform, we can swiftly identify and separate diseased animals from healthy ones, paving the way for targeted interventions. Through our dedicated efforts, we develop and administer disease-specific vaccines or utilize existing ones, disturbing the spread of zoonotic diseases. Join us on our mission to revolutionize disease management, as we strive to create healthier ecosystems and secure a brighter future for all.

Baltic BioTech Group

Holding Baltic Biotech Group (BBG) 3 companies were combined in 2023: Elbis Ltd, Loiterio Biotechnological services Ltd. (EBS) and LT Biotech Ltd. These companies entered the Biotech market in 1999, developing, manufacturing and supplying products and equipment.

Our Team

Co-Founder

Evgeny Kostin

Evgeny Kostin, 73, Professor, D.Sc, is the

co-founder of US BioTech. He lectured for many years at Vilnius University, and was the chairman of the department of Russian studies. He also was a founder and rector of the private Baltic Academy in Lithuania. Co-founder and CEO of the Russian-Lithuanian joint venture (1994-1998), and a strategic advisor to the big companies in Lithuania regarding its contacts in Germany, USA and Israel. He has extensive experience in PR and GR fields.

Co-Founder

Pavel Loiteris

Pavel Loiteris, 73, PhD, is the co-founder of US BioTech. He is also the President of Baltic Biotech Group, where his main responsibilities include general management & international projects. Before joining US Biotech, Dr. Loiteris worked for 16 years at the USSR Academy of Sciences and managed the organization of several international projects. After completing his academic career, he established several successful R&D and business ventures in various fields of biotechnology.

PHOTO-2023-07-07-07-39-54_edited_edited.

Senior Scientist

Vladyslav Spiridonov

Vladyslav Spiridonov, 50, Senior Scientist and Associated professor in animal biotechnology (2019), Doctor of sciences in animal biotechnology (2011), PhD in biochemistry (2003), Master of sciences in molecular biology (2000), Awarded Ukrainian National Scientific Prize 2008 for the development of epizootic monitoring, immunization and diagnosis of highly pathogenic avian influenza in Ukraine (Certificate № 6325). He is the author of numerous publications and patents in the field of molecular biology and genetics of animal sciences. His area of interest is in development of new methods for IVD of agricultural products.

Shareholder

Pavel Korabliov

Pavel Korabliov, 37, Shareholder, PhD in Immunology (2018), Master neurobiology (2011). He has many years of experience in organizing research and production projects, as well as, the Director of the Baltic Biotech Group holding. His main interests are in the development of innovative molecular diagnostic tools.

Shareholder

Sergei Loiter

Sergei Loiter, 39, Shareholder, MBA Harvard Business School (2013), Associate at McKinsey & Company, Deputy CEO & Head of Business Development at JSC TSUM, Chief Commercial Officer at Yandex. His main interest is in management, financial & market analysis, and business development.